Axcelis Technologies, Inc. (ACLS)
| Market Cap | 3.43B +29.2% |
| Revenue (ttm) | 890.24M +4.3% |
| Net Income | 104.56M -23.1% |
| EPS | 3.36 -20.8% |
| Shares Out | 30.88M |
| PE Ratio | 33.05 |
| Forward PE | 21.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 369,777 |
| Open | 111.04 |
| Previous Close | 106.79 |
| Day's Range | 109.45 - 116.81 |
| 52-Week Range | 73.60 - 193.78 |
| Beta | 1.89 |
| Analysts | Buy |
| Price Target | 132.00 (+18.74%) |
| Earnings Date | Nov 5, 2026 |
About ACLS
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor ch... [Read more]
Financial Performance
In 2025, Axcelis Technologies's revenue was $839.05 million, a decrease of -17.57% compared to the previous year's $1.02 billion. Earnings were $120.24 million, a decrease of -40.18%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for ACLS stock is "Buy." The 12-month stock price target is $132.0, which is an increase of 18.74% from the latest price.
News
Axcelis price target lowered to $116 from $145 at BofA
BofA analyst Duksan Jang lowered the firm’s price target on Axcelis (ACLS) to $116 from $145 and keeps an Underperform rating on the shares. The firm says the company is…
Axcelis price target lowered to $140 from $165 at B. Riley
B. Riley lowered the firm’s price target on Axcelis (ACLS) to $140 from $165 and keeps a Buy rating on the shares. The firm views the company’s Q3 report as…
Axcelis upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst Christian Schwab upgraded Axcelis (ACLS) to Buy from Hold with an unchanged price target of $140.
Axcelis Technologies Earnings Call Transcript: Q3 2026
Q3 revenue and EPS exceeded expectations as bookings strengthened across end markets, with backlog at $531M. Growth is expected in 2027 across memory, power, general mature and CS&I.
Axcelis Technologies Earnings release: Q3 2026
Axcelis Technologies released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Axcelis Technologies Slides: Q3 2026
Axcelis Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
Axcelis Technologies Quarterly report: Q3 2026
Axcelis Technologies has published its Q3 2026 quarterly earnings report on November 5, 2026.
Axcelis Announces Financial Results for Third Quarter 2026
Q3 2026 Highlights: Revenue of $237.8 million GAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2% GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6% GAAP Diluted Earnings...
Axcelis and Veeco provide update on expected timing of merger closing
Axcelis (ACLS) and Veeco Instruments (VECO) provided an update on the expected timing of the all-stock merger of Axcelis and Veeco. The companies now expect the transaction to close by…
Axcelis Technologies and Veeco Instruments Provide Update on Expected Timing of Merger Closing
Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y.
Axcelis names Jeroen Delsman as CFO, succeeding David Ryzhik
Axcelis (ACLS) Technologies announced the appointment of Jeroen Delsman as Executive Vice President and CFO, effective November 12. David Ryzhik, who has served as Interim CFO during the transition pe...
Axcelis Technologies Names Jeroen Delsman as Executive Vice President and Chief Financial Officer
BEVERLY, Mass., Oct. 27, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced the a...
Axcelis Announces Timing and Availability of Third Quarter 2026 Results and Conference Call
BEVERLY, Mass., Oct. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will release financia...
Axcelis to start construction of new manufacturing facility in Pyeongtaek, Korea
Axcelis (ACLS) Technologies announced that it will officially break ground on its new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea. This $35M investment re...
Axcelis to Begin Construction of New Manufacturing Facility in Pyeongtaek, Korea
$35 Million Investment Will Expand Axcelis' Manufacturing Capacity and Enable the Company to Better Serve Customers BEVERLY, Mass., Oct. 20, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: AC...
Axcelis price target lowered to $165 from $198 at B. Riley
B. Riley lowered the firm’s price target on Axcelis (ACLS) to $165 from $198 and keeps a Buy rating on the shares. The firm trimmed price targets for several semi…
Axcelis Announces Sponsorship and Participation in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026)
BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participatin...
Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026
BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum S...
Axcelis to build new manufacturing facility in Pyeongtaek, Korea
Axcelis (ACLS) Technologies announced plans to invest $35M in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek,...
Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans...
Axcelis Announces Participation in Upcoming Investor Conferences
BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company...
Axcelis price target raised to $198 from $180 at B. Riley
B. Riley analyst Craig Ellis raised the firm’s price target on Axcelis (ACLS) to $198 from $180 and keeps a Buy rating on the shares. The company’s Q2 report and…
Axcelis downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Christian Schwab downgraded Axcelis (ACLS) to Hold from Buy with a price target of $140, down from $173. The company reported a Q2 beat but its revenue outlook…
Axcelis Technologies Earnings Call Transcript: Q2 2026
Q2 2026 revenue and EPS exceeded expectations, driven by strong execution and demand in power, memory, and CS&I segments. Full-year revenue growth is now projected at mid-single digits, with continued momentum into 2027 and progress on the Veeco merger.
Axcelis Technologies Earnings release: Q2 2026
Axcelis Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.